Fiche publication
Date publication
mai 2013
Auteurs
Membres identifiés du Cancéropôle Est :
Dr LEBEAU Luc
,
Dr ZUBER Guy
,
Pr PONS Françoise
Tous les auteurs :
Pierrat P, Kereselidze D, Wehrung P, Zuber G, Pons F, Lebeau L
Lien Pubmed
Résumé
PURPOSE: Biolabile cationic lipids were developed for efficient intracellular delivery of DNA and siRNA. METHODS: The compounds have been designed starting from the membrane lipid DOPC in a way they may loose their cationic charge when exposed to an acidic and/or enzymatic stimulus, such as those met during the journey of a lipoplex in biological media. RESULTS: They demonstrated remarkable efficiency to deliver DNA in various cell lines (BHK-21, Calu-3, NCI-H292, and A549), with no significant cytotoxicity. Furthermore, two of the compounds (carbonate-based DOPC derivatives) revealed able to deliver small interfering RNA in U87Luc and A549Luc cancer cells and to mediate a selective 70-80% knockdown of the stably transfected luciferase gene. CONCLUSIONS: The results show that the described bioresponsive cationic lipids have high DNA and siARN delivery activity which is encouraging in view of delivering a therapeutic nucleic acid to pulmonary tissues in vivo.
Référence
Pharm Res. 2013 May;30(5):1362-79
